Keywords: archemix, initiates, ph, ii, anti-vwf, drug, trial

Archemix initiates Ph II anti-VWF drug trial

Article | 02 April 2009

Archemix, a US privately-held biotechnology company working to develop aptamer-based therapeutics, has initiated a Phase IIa clinical trial of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Aspirin

Bayer

Go to drug listing